Skip to main content

Retail Clinics

  • FDA approves Par and Tris Pharma's generic Tussionex

    WOODCLIFF LAKE, N.J. The Food and Drug Administration has approved a generic treatment for cough and upper respiratory symptoms resulting from colds and allergies made by Par Pharmaceutical and Tris Pharma, Par said Tuesday.

    The FDA approved hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension. The drug is a generic version of UCB’s Tussionex, which has annual sales of around $226 million, according to IMS Health.

     

  • Take Care Health Systems' treatment of pharyngitis, upper respiratory infections exceeds national quality benchmarks

    CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, announced on Monday that treatment of pharyngitis and upper respiratory infections at its clinics exceed national quality benchmarks, according to an analysis of data collected through its EMR system by the Jefferson School of Population Health.

  • J&J chairman addresses McNeil 'phantom recall' before House committee

    WASHINGTON McNeil products soon will repopulate shelves, Johnson & Johnson chairman and CEO Bill Weldon shared on Thursday during his testimony before the House of Representatives Committee on Oversight and Government Reform.

     

  • Mylan's generic Wellbutrin XL enters market

    PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.

     

    Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.

     

     

    The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.

     

  • Kaiser Family Foundation: Medicaid enrollment, spending rises; growth will continue

    WASHINGTON Due to the nation’s deep recession, states experienced rapid growth in their Medicaid enrollment and spending last year and expect additional growth, though at a slower pace, in fiscal year 2011, according to a survey of state Medicaid officials in all 50 states released Thursday by the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured.

     

  • FDA tentatively approves generic Crestor

    MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries.

    Sun announced Wednesday the tentative approval of rosuvastatin calcium tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths.

  • GSK, Mia Hamm to adults: 'Give your health a shot'

    PHILADELPHIA GlaxoSmithKline has tapped soccer star Mia Hamm for its public health campaign to emphasize the need for adults to make vaccinations part of their overall health-and-wellness goals.

    GSK's Give Your Health a Shot campaign underscores the need for adults to receive vaccinations as a preventative measure to protect their health. The campaign announcement followed the pertussis (whooping cough) outbreak that has affected California.

  • Boo-boos be gone with Smith & Nephew's No-Sting Skin-Prep spray

    ST. PETERSBURG, Fla. Smith & Nephew has created a liquid film-forming dressing that dries in less than 30 seconds.

    The company's alcohol-free No-Sting Skin-Prep spray has a four-day wear time and leaves a clear, waterproof, breathable and conformable barrier that allows for visual assessment of the periwound area.

     

X
This ad will auto-close in 10 seconds